Aptamer – “good visibility on its commercial pipeline going into the second half”. Really?‘Novel Optimer binders to enable innovation in the life sciences industry’ group Aptamer (APTA) has issued a “Half Year Trading Update” emphasising that “2022 has seen significant progress for Aptamer with the investment in new facilities to create more capacity and an expanded team, especially in sales and marketing” and that it “has good visibility on its commercial pipeline going into the second half, including a further £1.0m of current signed orders, as well as contracts in negotiation and strong expressions of interest across all three business units… remains focused on delivering market expectations for the full year”. So what of a current share price response down almost 7% to 47.5p?
- By Steve Moore
- 2023-01-03 11:09:29